Intervention Insights develops OncInsights, a bioinformatics product that analyzes cancerous tissue to generate a genomic profile of over 20,000 genes and corresponding molecular pathways. The company electronically delivers reports to community oncologists to support individualized treatment decisions. Intervention Insights is based on Van Andel Research Institute’s bioinformatics platform and is led by CEO Jerry Callahan. The company intends to use the new funding to expand commercialization efforts for OncInsights. Intervention Insights was founded in 2009 and is based in Grand Rapids, Mich. The recent financing strengthens its position to scale clinical adoption of its reporting service.

Total raised

$7M

Funding rounds

1

Latest round

Series B

Latest activity

Jul 2011